Literature DB >> 1976705

Heterogeneity of helper/inducer T lymphocytes. III. Responses of IL-2- and IL-4-producing (Th1 and Th2) clones to antigens presented by different accessory cells.

T L Chang1, C M Shea, S Urioste, R C Thompson, W H Boom, A K Abbas.   

Abstract

Murine CD4+ T cell clones have been classified into at least two subsets, Th1 and Th2, on the basis of their distinct lymphokine secretion profiles and functions. In the present study, we compared the functional responses of Th1 and Th2 clones to Ag presentation by splenic B cells and peritoneal macrophages. Th2 clones secreted IL-4 in response to Ag presented by resting B cells, but their optimal proliferation required the addition of IL-1 or a source of IL-1. The degree of IL-1 dependence varied among the four Th2 clones examined. In contrast, Th1 clones secreted IL-2 and proliferated in response to Ag presented by both B cells and macrophages, without any requirement for exogenous IL-1. Furthermore, the proliferation of Th2 clones in response to Ag presented by splenocytes or macrophages was inhibited by an IL-1R antagonist. These results indicate that IL-1 is an important costimulator for the expansion of the Th2 subset of CD4+ T cells. The different requirements for the proliferation of Th1 and Th2 cells may be responsible for the preferential expansion of one or the other subset under different conditions of immunization.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1976705

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  34 in total

Review 1.  Cytokines in asthma.

Authors:  K F Chung; P J Barnes
Journal:  Thorax       Date:  1999-09       Impact factor: 9.139

2.  Immature B lymphocytes from adult bone marrow exhibit a selective defect in induced hyperexpression of major histocompatibility complex class II and fail to show B7.2 induction.

Authors:  S Marshall-Clarke; L Tasker; R M Parkhouse
Journal:  Immunology       Date:  2000-06       Impact factor: 7.397

Review 3.  Pathophysiological mechanisms of asthma. Application of cell and molecular biology techniques.

Authors:  K F Chung; I M Adcock
Journal:  Mol Biotechnol       Date:  2001-07       Impact factor: 2.695

Review 4.  Cell and molecular biology of chemical allergy.

Authors:  I Kimber; R J Dearman
Journal:  Clin Rev Allergy Immunol       Date:  1997       Impact factor: 8.667

5.  The demonstration of an essential role for macrophages in the in vivo generation of IgG2a antibodies.

Authors:  J M Brewer; J Richmond; J Alexander
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330

6.  Inducible interleukin-4-secreting cells provoked in mice during chemical sensitization.

Authors:  R J Dearman; L S Ramdin; D A Basketter; I Kimber
Journal:  Immunology       Date:  1994-04       Impact factor: 7.397

7.  Cytokine control of parasite-specific anergy in human lymphatic filariasis. Preferential induction of a regulatory T helper type 2 lymphocyte subset.

Authors:  C L King; S Mahanty; V Kumaraswami; J S Abrams; J Regunathan; K Jayaraman; E A Ottesen; T B Nutman
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

8.  Differential antibody isotype reactivity to specific antigens in human lymphatic filariasis: gp15/400 preferentially induces immunoglobulin E (IgE), IgG4, and IgG2.

Authors:  M Yazdanbakhsh; W A Paxton; A Brandenburg; R Van Ree; M Lens; F Partono; R M Maizels; M E Selkirk
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

9.  Different migration patterns of antigen-presenting cells correlate with Th1/Th2-type responses in mice.

Authors:  Y Morikawa; K Tohya; H Ishida; N Matsuura; K Kakudo
Journal:  Immunology       Date:  1995-08       Impact factor: 7.397

10.  Differential regulation of T helper phenotype development by interleukins 4 and 10 in an alpha beta T-cell-receptor transgenic system.

Authors:  C S Hsieh; A B Heimberger; J S Gold; A O'Garra; K M Murphy
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.